| 27 May 2025 | Change of Name |
| 22 May 2025 | Result of AGM |
| 2 May 2025 | Application: FDA Breakthrough Therapy Designation |
| 27 May 2025 | Change of Name |
| 22 May 2025 | Result of AGM |
| 2 May 2025 | Application: FDA Breakthrough Therapy Designation |
| 29 Apr 2025 | Notice of AGM |
| 25 Apr 2025 | Publication of Annual Report |
| 11 Apr 2025 | Promising Preliminary Results of Phase 1 Study |
| 18 Mar 2025 | Placing to raise £250,000 |
| 3 Feb 2025 | IB Expands Distribution with Blackford |
| 22 Jan 2025 | Operations Update |
| 10 Jan 2025 | IB and Prism Secure First Installation |